Table 3.

Relationship between CHRM3 expression and clinicopathological features of endometrial carcinoma patients

	CHRM3				P Value
	Low	%	High	%
Age (years)
< 45	11	4.3	13	5.1	0.831
≥ 45	116	45.1	117	45.5
Pregnancy
No	5	1.9	8	3.1	0.571
Yes	122	47.5	122	47.5
Pathological type
Adenocarcinoma	119	46.3	114	44.4	0.133
Squamous carcinoma, papillary serous carcinoma, and clear cell carcinoma	8	3.1	16	6.2
Stage
I	113	44.0	103	40.1	0.009**
II	10	3.9	9	3.5
III and IV	4	1.5	18	7.0
Grade
G1	71	27.6	73	28.4	0.796
G2	37	14.4	41	16.0
G3	19	7.4	16	6.2
Vascular invasion
No	122	47.5	113	44.0	0.013*
Yes	5	1.9	17	6.6
Lymphatic metastasis
No	125	48.6	118	45.9	0.011*
Yes	2	0.8	12	4.7

^* P < 0.05;

^** P < 0.01.